serw-MX  [xml]
/inhibitors CID10 - Classificação Internacional de Doenças DeCS Português DeCS Inglês DeCS Espanhol DeCS Espanha DeCS Português com escopo DeCS Inglês com escopo DeCS Espanhol com escopo DeCS Espanha com escopo LILACS - LILACS Regional
DeCS Categories D27 Chemical Actions and Uses . D27.505 Pharmacologic Actions . D27.505.519 Molecular Mechanisms of Pharmacological Action . D27.505.519.389 Enzyme Inhibitors . D27.505.519.389.092 Adenosine Deaminase Inhibitors . D27.505.519.389.739 Poly(ADP-ribose) Polymerase Inhibitors . D27.505.519.389.745 Protease Inhibitors . D27.505.519.389.745.085 Angiotensin-Converting Enzyme Inhibitors . D27.505.954 Therapeutic Uses . D27.505.954.248 Antineoplastic Agents . D27.505.954.248.692 Poly(ADP-ribose) Polymerase Inhibitors . F01 Behavior and Behavior Mechanisms . F01.145 Behavior . F01.145.544 Inhibition (Psychology) . F02 Psychological Phenomena . F02.463 Mental Processes . F02.463.425 Learning . F02.463.425.475 Inhibition (Psychology) . F02.739 Psychological Theory . F02.739.794 Psychoanalytic Theory . F02.739.794.405 Inhibition (Psychology) .		Terms  Synonyms & Historicals Documents LILACS e MDL   /antagonists & inhibitors . /antagonists and inhibitors . /antagonists . /inhibitors . Used with chemicals, drugs, and endogenous substances to indicate substances or agents which counteract their biological effects by any mechanism. . 1.00   Angiotensin-Converting Enzyme Inhibitors . Angiotensin I-Converting Enzyme Inhibitors . Angiotensin-Converting Enzyme Antagonists . Antagonists, Angiotensin-Converting Enzyme . Antagonists, Kininase II . Inhibitors, ACE . Inhibitors, Angiotensin-Converting Enzyme . Inhibitors, Kininase II . Kininase II Antagonists . Angiotensin Converting Enzyme Antagonists . Angiotensin Converting Enzyme Inhibitors . Angiotensin I Converting Enzyme Inhibitors . Antagonists, Angiotensin Converting Enzyme . Enzyme Antagonists, Angiotensin-Converting . Enzyme Inhibitors, Angiotensin-Converting . Inhibitors, Angiotensin Converting Enzyme . Kininase II Inhibitors . ACE Inhibitors . A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. . 0.83   Inhibition (Psychology) . Inhibition . Inhibitions . Inhibitions (Psychology) . The interference with or prevention of a behavioral or verbal response even though the stimulus for that response is present; in psychoanalysis the unconscious restraining of an instinctual process. . 0.81   Poly(ADP-ribose) Polymerase Inhibitors . Inhibitors of Poly(ADP-ribose) Polymerases . PARP Inhibitors . Poly(ADP-ribosylation) Inhibitors . Inhibitors, PARP . Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES. . 0.81   Adenosine Deaminase Inhibitors . ADA Inhibitors . Deaminase Inhibitors, Adenosine . Inhibitors, ADA . Inhibitors, Adenosine Deaminase . Drugs that inhibit ADENOSINE DEAMINASE activity. . 0.81   Protease Inhibitors . Antiproteases . Protease Inhibitor . Antagonists, Protease . Hydrolase Inhibitors, Peptide . Inhibitor, Protease . Inhibitors, Endopeptidase . Inhibitors, Peptidase . Inhibitors, Peptide Hydrolase . Inhibitors, Peptide Peptidohydrolase . Inhibitors, Protease . Peptidohydrolase Inhibitors, Peptide . Endopeptidase Inhibitors . Peptidase Inhibitors . Peptide Hydrolase Inhibitors . Peptide Peptidohydrolase Inhibitors . Protease Antagonists . Proteinase Inhibitors . Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). . 0.78